Benjamin Kleinstiver, Ph.D.
Center for Genomic Medicine, Mass General Research Institute
Assistant Professor of Pathology
Harvard Medical School
Pathology, Massachusetts General Hospital
|PHD University of Western Ontario 2013|
Genome editing technologies offer hope for the correction of disorders that are the result of mutations in a patient’s DNA. Dr. Kleinstiver's research group pursues protein engineering strategies to improve important properties of CRISPR genome editing nucleases (including their activities, specificities, and targeting ranges), while also exploring the feasibility of applying these engineered technologies for the treatment of genetic diseases.
Dr. Kleinstiver is a Principal Investigator in the Center for Genomic Medicine at the Massachusetts General Hospital (MGH) and Harvard Medical School (HMS).
Research in the Kleinstiver laboratory is supported by an NIH Transition to Independence Award, an ASGCT Career Development Award, and a Landenberger Research Foundation Award.
Visit the Kleinstiver Lab website at www.kleinstiverlab.org.